Related Experiment Video
Updated: Mar 29, 2026
08:43
Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
69.3K
Endoscopic Disease Activity in Inflammatory Bowel Disease
Shara Nguyen Ket1, Rebecca Palmer1, Simon Travis2,3
1Gastroenterology Unit, John Radcliffe Hospital, Oxford, UK.
Current Gastroenterology Reports
|December 10, 2015
Summary
Endoscopic scoring systems quantify mucosal disease activity in Crohn's disease and ulcerative colitis. This review details advances in these scoring systems for guiding treatment and clinical trials.
Area of Science:
- Gastroenterology
- Endoscopic assessment
- Inflammatory bowel disease (IBD)
Background:
- Endoscopic scoring systems are crucial for quantifying mucosal disease activity in Crohn's disease (CD) and ulcerative colitis (UC).
- These systems aim to provide objective measures of endoscopic severity to guide clinical management and therapeutic decisions.
- Mucosal healing is a recognized endpoint, but standardized endoscopic definitions remain unresolved despite numerous scoring systems.
Purpose of the Study:
- To review recent advancements in endoscopic scoring systems for ulcerative colitis and Crohn's disease.
- To highlight the role of these indices in assessing disease activity and response to therapy.
- To discuss the ongoing challenges in defining endoscopic remission and healing.
Main Methods:
- Systematic review of literature on endoscopic scoring systems for IBD.
- Analysis of recently developed and validated scoring systems for UC and CD.
- Comparison of different indices based on their components, scoring, and clinical utility.
Main Results:
- Several scoring systems for UC, including the Mayo Clinic endoscopy subscore, UCEIS, and UCCIS, have been developed.
- Advances in Crohn's disease endoscopic scoring are also discussed.
- The review synthesizes current knowledge on the application and limitations of these tools.
Conclusions:
- Endoscopic scoring systems are vital for objective assessment and management of IBD.
- Continued development and validation are needed to standardize definitions of mucosal healing and endoscopic remission.
- These refined tools will improve the reliability of clinical trials and patient care.
More Related Videos
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
10.8K
09:42Murine Endoscopy for In Vivo Multimodal Imaging of Carcinogenesis and Assessment of Intestinal Wound Healing and Inflammation
Published on: August 26, 2014
19.6K
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
1.5K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
1.0K
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.0K
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
1.4K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.4K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
932
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
932
01:17Chronic Bowel Disorders: Introduction
904
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
904
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
740
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
740